Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering
26 May 2023 Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering …
26 May 2023 Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering …
26 May 2023 Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering …
INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and…
INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and…
LONDON, May 26, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health…
LONDON, May 26, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health…
Daix (France), Long Island City (New York, United States), May 26, 2023 – Inventiva…
Vancouver, British Columbia–(Newsfile Corp. – May 26, 2023) – Legend Power® Systems Inc. (TSXV: LPS)…
BELLEVUE, Wash.–(BUSINESS WIRE)–$NVOS #AAPI–Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic…
MENLO PARK, Calif. & ATLANTA–(BUSINESS WIRE)–As the US and countries around the globe face a…
HARTFORD, Conn. & BOSTON–(BUSINESS WIRE)–Eversource Energy (NYSE: ES) today announced the election of Daniel J….
HUNT VALLEY, Md.–(BUSINESS WIRE)–TESSCO TECHNOLOGIES INCORPORATED (NASDAQ: TESS) today reported financial results for its fiscal…
DALLAS–(BUSINESS WIRE)–Leeward Renewable Energy Operations, LLC (“LREO”) today announced that it has posted to its…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA affirms the BBB issuer and senior unsecured debt ratings for FS KKR…
HOUSTON–(BUSINESS WIRE)–ConocoPhillips (NYSE: COP) today announced that it is exercising its preemption right to purchase…
Evaluation is based on the company’s Ability to Execute and Completeness of Vision MOUNTAIN VIEW,…
Changes in Guerbet’s Board of Directors Appointment of Didier Izabel as Chair of the Board…
U.S. engineering batches support planned expansion of its ongoing NEXICART-1 (NCT04720313) NXC-201 CAR-T clinical trial…
U.S. engineering batches support planned expansion of its ongoing NEXICART-1 (NCT04720313) NXC-201 CAR-T clinical trial…
XI’AN, China, May 26, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…